Nanosonics (ASX: NAN) — Stock Profile

Nanosonics Limited is an infection prevention company that manufactures, distributes, and commercialises infection control and decontamination products and related technologies across Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company's core focus spans the development of ultrasound probe disinfection systems alongside their associated consumables, accessories, and supporting digital infrastructure.

Its principal product line centres on the trophon family of ultrasound probe disinfectors, which includes the trophon EPR, a device built around patented sonicated mist technology capable of providing high level disinfection of both endocavitary and surface ultrasound probes, and the trophon2, an enhanced iteration offering new functionality through AcuTrace, a tool designed for audit-ready digital record-keeping and integration with hospital IT systems. The company also offers AuditPro, an infection control workflow compliance management solution, and CORIS, an instrument reprocessing product platform. Incorporated in 2000, Nanosonics is headquartered in Macquarie Park, Australia.